+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06657833

Treatment of Calcified Nodules with Drug Eluting Balloon or Drug Eluting Stent After Intravascular Lithotripsy An International Randomized Trial

Led by Fundación EPIC · Updated on 2026-09-30

128

Participants Needed

15

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating treatment options for patients with coronary artery disease caused by calcified nodules. This international, multicenter, open-label randomized trial compares two approaches after using intravascular lithotripsy to modify the plaque drug eluting balloons DEB and drug eluting stents DES. The study aims to assess the safety and effectiveness of these treatments and to determine if DEB is at least as good or possibly better than DES in this setting. Participants undergo a percutaneous coronary intervention PCI involving intravascular lithotripsy to break up the calcified plaques. They are then randomly assigned to receive either a drug eluting balloon or a drug eluting stent to treat the lesion. This leave-nothing-behind strategy is studied for its potential to reduce risks related to stent placement. The trial follows patients for outcomes up to 24 months, with key measurements at 9 and 12 months. During the study, participants receive imaging to confirm the calcified nodule lesion and have follow-up angiographic assessments. Researchers monitor outcomes including late lumen loss and net lumen gain at 9 months, as well as safety events such as vessel dissection, perforation, thrombosis, and major adverse cardiac events up to 24 months. The trial also tracks additional measures like minimal lumen diameter and target lesion revascularization. Participation lasts through treatment and extended follow-up to evaluate both effectiveness and safety.

CONDITIONS

Brief Title

DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.

Research Team

F

FUNDACION EPIC

A

ALFONSO JURADO ROMAN, MD,PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here